Drug Executive Collapses During Oval Office Press Conference
A drug executive fainted in the Oval Office while President Donald Trump announced a deal with drugmakers to reduce obesity drug prices. The press conference was abruptly interrupted on Thursday.
Incident Details
The man who collapsed was identified as Gordon Findlay, the global brand director for Novo Nordisk. During remarks by David Ricks, CEO of Eli Lilly, Ricks noticed Findlay and asked,
“Are you okay? Gordon, are you okay?”
Immediate Response
Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, quickly intervened as Findlay fell to his knees and collapsed. Attendees, including Health and Human Services Secretary, were present at the time.
Press Conference Resumption
The press was asked to leave the room immediately following the incident. About 30 minutes later, the press conference resumed, with President Trump providing an update on Findlay's condition.
Background on the Announcement
President Trump, along with drugmakers Eli Lilly and Novo Nordisk, discussed a deal to expand coverage and lower prices for popular obesity treatments Zepbound and Wegovy.
Summary: During an Oval Office event on lowering obesity drug prices, Novo Nordisk's Gordon Findlay collapsed, prompting quick medical attention and a temporary pause in the press conference.